A recently published review of reports of complications of suture-based vascular closure devices from the US Food & Drug Administration MAUDE (Manufacturer and User Facility Device Experience) post-marketing surveillance database identified 827 reports of major complications with Perclose ProGlide (Abbott Cardiovascular; Abbott Park, IL) and 175 reports of major complications with Prostar XL (Abbott Cardiovascular; Abbott Park, IL).